Compare Lockheed Martin Corporation (LMT) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lockheed Martin Corporation vs Novavax Inc — how do they compare? Lockheed Martin Corporation trades at $597.2 (market cap $137.96B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: Lockheed Martin Corporation is far larger — about 105.3× Novavax Inc's market cap, and Lockheed Martin Corporation pays a 2.31% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| LMT | NVAX | |
|---|---|---|
Market Cap | $137.96B | $1.31B |
Sector | Industrials | Health |
52-Week High | $676.70 | $11.19 |
52-Week Low | $431.56 | $6.22 |
Enterprise Value | $154.71B | $889.30M |
Dividend Yield | 2.31% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lockheed Martin Corporation
Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
